NIHR Imperial BRC 2022 to 25 in numbers
These figures highlight the scale and impact of our research over three years, showing how our work supports advances in prevention, diagnosis and treatment.
Impact highlights
0
research papers published
0
first patients recruited to commercial trials in the UK, and 2 first patients globally
0
studies opened or running
0
patients recruited
0
trainees, including nurses, midwives and allied health professionals
0
patents filed, with 19 granted
0
studies delivering treatments in humans for the first time
0
national clinical or policy guidelines citing our research